I-Mab (IMAB)
NASDAQ: IMAB · Real-Time Price · USD
0.970
+0.003 (0.35%)
Feb 21, 2025, 4:00 PM EST - Market closed
I-Mab Revenue
I-Mab had revenue of $569.46K in the twelve months ending September 30, 2024, down -100.50% year-over-year. In the year 2023, I-Mab had annual revenue of $27.64M, down -112.48%.
Revenue (ttm)
$569.46K
Revenue Growth
-100.50%
P/S Ratio
139.07
Revenue / Employee
$2,588
Employees
220
Market Cap
78.99M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
IMAB News
- 4 days ago - I-Mab to Participate in Leerink Partners Global Healthcare Conference - GlobeNewsWire
- 18 days ago - I-Mab to Present at Oppenheimer's 35th Annual Healthcare Life Sciences Conference - GlobeNewsWire
- 6 weeks ago - I-Mab Announces Open Market Purchases of Company American Depositary Shares by Board Member - PRNewsWire
- 6 weeks ago - I-Mab Announces Portfolio Prioritization of Givastomig (CLDN18.2 x 4-1BB Bispecific Antibody) as Lead Clinical Program - PRNewsWire
- 3 months ago - I-Mab to Participate at the Piper Sandler Healthcare Conference - PRNewsWire
- 3 months ago - I-Mab Reports Third Quarter 2024 Results - PRNewsWire
- 3 months ago - I-Mab Appoints Sean Fu, PhD, MBA, as Chief Executive Officer - PRNewsWire
- 4 months ago - I-Mab to Release Q3 2024 Financial Results on November 14, 2024 - PRNewsWire